Question

A clinical psychologist is studying the efficacy of a new drug medication for depression. The study...

A clinical psychologist is studying the efficacy of a new drug medication for depression. The study includes a placebo group (no medication) versus a treatment group (new medication). He then measures the differences in depressive symptoms across the two groups. What would a Type I error represent within the context of his study? How can he reduce the risk of committing a Type I error? How does this decision affect the risk of committing a Type II error?

Homework Answers

Answer #1

Dear Students,

If you like it , Please like it :) . Your feedback means a lot .

Thank you !!

Know the answer?
Your Answer:

Post as a guest

Your Name:

What's your source?

Earn Coins

Coins can be redeemed for fabulous gifts.

Not the answer you're looking for?
Ask your own homework help question
Similar Questions
A clinical psychologist is studying the efficacy of a new drug medication for depression. The study...
A clinical psychologist is studying the efficacy of a new drug medication for depression. The study includes a placebo group (no medication) versus a treatment group (new medication). He then measures the differences in depressive symptoms across the two groups. What would a Type I error represent within the context of his study? How can he reduce the risk of committing a Type I error? How does this decision affect the risk of committing a Type II error?
A clinical trial is being conducted in order to determine the efficacy of a new drug...
A clinical trial is being conducted in order to determine the efficacy of a new drug that will be used to treat type II diabetes. The efficacy of the medication will be determined by the blood glucose readings obtained from the patients. If the researcher wants a margin of error less than or equal to 5 mg/dL and the standard deviation for blood glucose readings among type II diabetics was previous documented as 15 mg/dL, how many patients should be...
A clinical trial is being conducted in order to determine the efficacy of a new drug...
A clinical trial is being conducted in order to determine the efficacy of a new drug that will be used to treat rheumatoid arthritis. The efficacy of the medication will not only be determined by the physical improvement of symptoms but will also be determined by using a blood test to examine the concentration of C-reactive protein (an inflammatory marker) in an individual's blood. If the researcher wants a margin of error for the level of C-reactive protein to be...
A clinical trial is being conducted in order to determine the efficacy of a new drug...
A clinical trial is being conducted in order to determine the efficacy of a new drug that will be used to treat Crohn’s disease. The efficacy of the medication will not only be determined by the physical improvement of symptoms but will also be determined by using a blood test to examine the concentration C-reactive protein (an inflammatory marker) in an individual’s blood. If the researcher wants a margin of error for the level of C-reactive protein to be less...
A research study was conducted to examine the clinical efficacy of a new antidepressant before being...
A research study was conducted to examine the clinical efficacy of a new antidepressant before being placed on the market. Depressed patients were randomly assigned to one of three groups: a placebo group, a group that received a low dose of the drug, and a group that received a moderate dose of the drug. After four weeks of treatment, the patients completed a depression inventory. The higher the score the more depressed the patient. The data are presented below. Placebo...
A manufacturer has produced a new drug for depression. The pharmaceutical company performed a study in...
A manufacturer has produced a new drug for depression. The pharmaceutical company performed a study in which 25 depressed subjects took the new medication and 25 depressed subjects took a placebo pill. Neither the subjects nor the examiners administering the questionnaire knew who was in the drug group and who was in the placebo group. After 2 months, the subjects who took the drug had significantly improved scores on a standardized depression symptom questionnaire. The only side effects seen with...
Here is the scenario that I am working on: The efficacy of a new addiction medication...
Here is the scenario that I am working on: The efficacy of a new addiction medication was evaluated in a randomized, placebo-controlled, doubleblind study. The medication in question, Antaquil, is intended to moderate the symptoms of alcohol withdrawal and craving with minimum side effects. Over the course of three weeks, a sample of 36 individuals who were recovering from alcohol addiction were randomly assigned to two groups: one administered the medication and one administered a placebo. At the end of...
A study examines how well a new drug treatment works to improve schizophrenia symptoms. One hundred...
A study examines how well a new drug treatment works to improve schizophrenia symptoms. One hundred patients with schizophrenia are randomly assigned to either a new drug or a placebo control group for an 8 week time period (50 in each group). A social worker assesses the number of symptoms during this time period. Is there a difference between the new drug treatment compared to the placebo in regard to how well it treats schizophrenia symptoms? Circle the correct one:...
1. ) Suppose a researcher is interested in the effectiveness of a new drug that is...
1. ) Suppose a researcher is interested in the effectiveness of a new drug that is intended to naturally increase hours of sleep for elderly patients experiencing insomnia above 5 hours. Suppose he collects information from a group of 64 patients, and calculates a sample mean of 6.4 hours of sleep and a standard deviation of s=0.8.   Write out your null and alternative hypotheses. Carry out the appropriate statistical test to determine if the new treatment is effective (One sided)?...
Which of the following is false concerning a radiolabeled drug disposition study in humans? Group of...
Which of the following is false concerning a radiolabeled drug disposition study in humans? Group of answer choices a. May lead to separate toxicology studies on a drug metabolite if exposure to that metabolite during administration of the parent drug is much lower in animal toxicology studies than in human clinical trials. b. Does not need to be conducted until after pivotal Phase 3 clinical trials are completed. c. Identifies major routes of drug elimination in humans. 2. We are...